Mouse Anti-DLG2 Recombinant Antibody (CBFYC-2587) (V2LY-0425-LY442)

Pass, R., Haan, N., Humby, T., Wilkinson, L. S., Hall, J., & Thomas, K. L. (2022). Selective behavioural impairments in mice heterozygous for the cross disorder psychiatric risk gene DLG2. Genes, Brain and Behavior, 21(4), e12799.

Yoo, T., Kim, S. G., Yang, S. H., Kim, H., Kim, E., & Kim, S. Y. (2020). A DLG2 deficiency in mice leads to reduced sociability and increased repetitive behavior accompanied by aberrant synaptic transmission in the dorsal striatum. Molecular Autism, 11(1), 1-14.

Shao, Y. W., Wood, G. A., Lu, J., Tang, Q. L., Liu, J., Molyneux, S., ... & Khokha, R. (2019). Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma. Oncogene, 38(2), 291-298.

Wu, H. C., Chen, C. M., Chen, Y. C., Fung, H. C., Chang, K. H., & Wu, Y. R. (2018). DLG2, but not TMEM229B, GPNMB, and ITGA8 polymorphism, is associated with Parkinson's disease in a Taiwanese population. Neurobiology of Aging, 64, 158-e1.

Ali, S., Hoven, A., Dress, R. J., Schaal, H., Alferink, J., & Scheu, S. (2018). Identification of a novel Dlg2 isoform differentially expressed in IFNβ-producing plasmacytoid dendritic cells. BMC genomics, 19(1), 1-12.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols